213 related articles for article (PubMed ID: 34383782)
21. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
Cao J; Qi X; Wang N; Chen Y; Xie B; Ma C; Chen Z; Xiong W
J Endocrinol Invest; 2023 Oct; 46(10):2005-2016. PubMed ID: 36849849
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy.
Seo Y; Chae MK; Han SA; Lee EJ; Lee JH; Yoon JS
Inflamm Res; 2017 Jun; 66(6):535-545. PubMed ID: 28364200
[TBL] [Abstract][Full Text] [Related]
23. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
[TBL] [Abstract][Full Text] [Related]
24. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
[TBL] [Abstract][Full Text] [Related]
25. Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects.
Li H; Ma C; Liu W; He J; Li K
Invest Ophthalmol Vis Sci; 2020 May; 61(5):64. PubMed ID: 32462203
[TBL] [Abstract][Full Text] [Related]
26. Curcumin Suppresses TGF-β1-Induced Myofibroblast Differentiation and Attenuates Angiogenic Activity of Orbital Fibroblasts.
Yu WK; Hwang WL; Wang YC; Tsai CC; Wei YH
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202024
[TBL] [Abstract][Full Text] [Related]
27. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
[TBL] [Abstract][Full Text] [Related]
28. Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.
Roh TH; Chae MK; Ko JS; Kikkawa DO; Jang SY; Yoon JS
Endocrinol Metab (Seoul); 2023 Dec; 38(6):739-749. PubMed ID: 37989267
[TBL] [Abstract][Full Text] [Related]
29. Role of Inositol-Requiring Enzyme 1 and Autophagy in the Pro-Fibrotic Mechanism Underlying Graves' Orbitopathy.
Lee CE; Kim JY; Yoon JS; Ko J
Yonsei Med J; 2024 Jul; 65(7):397-405. PubMed ID: 38910302
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.
Yoon JS; Chae MK; Lee SY; Lee EJ
Br J Ophthalmol; 2012 Aug; 96(8):1117-21. PubMed ID: 22661653
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.
Wei YH; Liao SL; Wang CC; Wang SH; Tang WC; Yang CH
Mediators Inflamm; 2021; 2021():8888913. PubMed ID: 33542676
[TBL] [Abstract][Full Text] [Related]
33. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
[No Abstract] [Full Text] [Related]
35. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
36. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy.
Plöhn S; Edelmann B; Japtok L; He X; Hose M; Hansen W; Schuchman EH; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5391-5397. PubMed ID: 30452592
[TBL] [Abstract][Full Text] [Related]
37. Signal transducer and activator of transcription 3 as a potential therapeutic target for Graves' orbitopathy.
Ko J; Kim JY; Kim BR; Lee EJ; Kikkawa DO; Yoon JS
Mol Cell Endocrinol; 2021 Aug; 534():111363. PubMed ID: 34116129
[TBL] [Abstract][Full Text] [Related]
38. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324
[TBL] [Abstract][Full Text] [Related]
39. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
40. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
